These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of Manufacturing Variables and Raw Materials on the Composition-Equivalent PLGA Microspheres for 1-Month Controlled Release of Leuprolide. Zhou J, Walker J, Ackermann R, Olsen K, Hong JKY, Wang Y, Schwendeman SP. Mol Pharm; 2020 May 04; 17(5):1502-1515. PubMed ID: 32074448 [Abstract] [Full Text] [Related]
4. Development of Level A in vitro-in vivo correlations for peptide loaded PLGA microspheres. Andhariya JV, Jog R, Shen J, Choi S, Wang Y, Zou Y, Burgess DJ. J Control Release; 2019 Aug 28; 308():1-13. PubMed ID: 31301338 [Abstract] [Full Text] [Related]
9. Polymer source affects in vitro-in vivo correlation of leuprolide acetate PLGA microspheres. Wan B, Bao Q, Wang R, Burgess DJ. Int J Pharm; 2022 Sep 25; 625():122032. PubMed ID: 35878870 [Abstract] [Full Text] [Related]
12. Sustained release of etanidazole from spray dried microspheres prepared by non-halogenated solvents. Wang FJ, Wang CH. J Control Release; 2002 Jun 17; 81(3):263-80. PubMed ID: 12044566 [Abstract] [Full Text] [Related]
14. Physical-Chemical Characterization of Octreotide Encapsulated in Commercial Glucose-Star PLGA Microspheres. Beig A, Feng L, Walker J, Ackermann R, Hong JKY, Li T, Wang Y, Qin B, Schwendeman SP. Mol Pharm; 2020 Nov 02; 17(11):4141-4151. PubMed ID: 32876463 [Abstract] [Full Text] [Related]
15. Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres. Wang J, Wang BM, Schwendeman SP. J Control Release; 2002 Aug 21; 82(2-3):289-307. PubMed ID: 12175744 [Abstract] [Full Text] [Related]
16. Influence of PLGA molecular weight distribution on leuprolide release from microspheres. Ochi M, Wan B, Bao Q, Burgess DJ. Int J Pharm; 2021 Apr 15; 599():120450. PubMed ID: 33675924 [Abstract] [Full Text] [Related]
17. Development and characterization of composition-equivalent formulations to the Sandostatin LAR® by the solvent evaporation method. Beig A, Feng L, Walker J, Ackermann R, Hong JKY, Li T, Wang Y, Schwendeman SP. Drug Deliv Transl Res; 2022 Mar 15; 12(3):695-707. PubMed ID: 34215997 [Abstract] [Full Text] [Related]
18. In vitro performance of composition-equivalent PLGA microspheres encapsulating exenatide acetate by solvent evaporation. Chandrashekar A, Beig A, Wang Y, Schwendeman SP. Int J Pharm; 2023 Aug 25; 643():123213. PubMed ID: 37423376 [Abstract] [Full Text] [Related]
19. Effect of polymer source on in vitro drug release from PLGA microspheres. Wan B, Andhariya JV, Bao Q, Wang Y, Zou Y, Burgess DJ. Int J Pharm; 2021 Sep 25; 607():120907. PubMed ID: 34332059 [Abstract] [Full Text] [Related]
20. Validation of a cage implant system for assessing in vivo performance of long-acting release microspheres. Doty AC, Hirota K, Olsen KF, Sakamoto N, Ackermann R, Feng MR, Wang Y, Choi S, Qu W, Schwendeman A, Schwendeman SP. Biomaterials; 2016 Dec 25; 109():88-96. PubMed ID: 27693924 [Abstract] [Full Text] [Related] Page: [Next] [New Search]